GO
Loading...

Johnson & Johnson

More

  • WASHINGTON, Sept 16- Leaders of some of the biggest U.S. corporations, from Coca-Cola Co to Johnson& Johnson, unveiled a campaign on Tuesday to reduce the nation's healthcare costs, urging their peers to embrace wellness programs to improve employee health.

  • Midday Glance: Medical Devices companies Tuesday, 16 Sep 2014 | 1:22 PM ET

    Allergan rose$. 99 or. 6 percent, to $169.55. Baxter International Inc. rose$. 40 or. 5 percent, to $74.95. Boston Scientific Corp. fell$. 03 or. 2 percent, to $12.36.

  • Midday Glance: Pharmaceuticals companies Tuesday, 16 Sep 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 40 or. 5 percent, to $74.95. Bristol-Myers Squibb Co. rose$. 74 or 1.5 percent, to $50.69. Hospira rose$. 30 or. 6 percent, to $53.09.

  • Early Glance: Medical Devices companies Tuesday, 16 Sep 2014 | 10:43 AM ET

    Allergan rose $1.02 or. 6 percent, to $169.58. Baxter International Inc. rose$. 25 or. 3 percent, to $74.80. Boston Scientific Corp. fell$. 08 or. 6 percent, to $12.31.

  • Early Glance: Pharmaceuticals companies Tuesday, 16 Sep 2014 | 10:43 AM ET

    Baxter International Inc. rose$. 25 or. 3 percent, to $74.80. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $50.11. Hospira rose$. 01 or percent, to $52.80.

  • Final Glance: Pharmaceuticals companies Monday, 15 Sep 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 15 or. 2 percent, to $74.55. Bristol-Myers Squibb Co. fell$. 31 or. 6 percent, to $49.95. Hospira rose$. 16 or. 3 percent, to $52.79.

  • Final Glance: Medical Devices companies Monday, 15 Sep 2014 | 6:03 PM ET

    Allergan fell$. 69 or. 4 percent, to $168.56. Baxter International Inc. fell$. 15 or. 2 percent, to $74.55. Boston Scientific Corp. fell$. 11 or. 9 percent, to $12.39.

  • Sept 15- Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year.

  • Midday Glance: Medical Devices companies Monday, 15 Sep 2014 | 1:24 PM ET

    Allergan rose$. 29 or. 2 percent, to $169.54. Baxter International Inc. fell$. 31 or. 4 percent, to $74.39. Boston Scientific Corp. fell$. 10 or. 8 percent, to $12.41.

  • Midday Glance: Pharmaceuticals companies Monday, 15 Sep 2014 | 1:24 PM ET

    Baxter International Inc. fell$. 31 or. 4 percent, to $74.39. Bristol-Myers Squibb Co. fell$. 32 or. 6 percent, to $49.95. Hospira rose$. 18 or. 3 percent, to $52.81.

  • Early Glance: Medical Devices companies Monday, 15 Sep 2014 | 10:37 AM ET

    Allergan fell$. 74 or. 4 percent, to $168.51. Baxter International Inc. fell$. 40 or. 5 percent, to $74.30. Boston Scientific Corp. fell$. 08 or. 6 percent, to $12.42.

  • Early Glance: Pharmaceuticals companies Monday, 15 Sep 2014 | 10:37 AM ET

    Baxter International Inc. fell$. 40 or. 5 percent, to $74.30. Bristol-Myers Squibb Co. fell$. 27 or. 5 percent, to $49.99. Johnson& Johnson fell$. 05 or percent, to $104.53.

  • LOS ANGELES, Sept 12- The next generation version of Gilead Sciences Inc's $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive.

  • Final Glance: Medical Devices companies Friday, 12 Sep 2014 | 6:02 PM ET

    Allergan rose$. 92 or. 5 percent, to $169.25. Baxter International Inc. fell$. 39 or. 5 percent, to $74.70. Boston Scientific Corp. fell$. 04 or. 3 percent, to $12.50.

  • Final Glance: Pharmaceuticals companies Friday, 12 Sep 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $74.70. Bristol-Myers Squibb Co. fell$. 42 or. 8 percent, to $50.26. Hospira fell$. 36 or. 7 percent, to $52.63.

  • Midday Glance: Medical Devices companies Friday, 12 Sep 2014 | 1:19 PM ET

    Allergan rose$. 56 or. 3 percent, to $168.89. Baxter International Inc. fell$. 43 or. 6 percent, to $74.66. Boston Scientific Corp. fell$. 03 or. 2 percent, to $12.51.

  • Midday Glance: Pharmaceuticals companies Friday, 12 Sep 2014 | 1:19 PM ET

    Baxter International Inc. fell$. 43 or. 6 percent, to $74.66. Bristol-Myers Squibb Co. fell$. 40 or. 8 percent, to $50.28. Hospira fell$. 35 or. 7 percent, to $52.64.

  • Early Glance: Medical Devices companies Friday, 12 Sep 2014 | 11:13 AM ET

    Allergan fell$. 22 or. 1 percent, to $168.12. Baxter International Inc. fell$. 26 or. 3 percent, to $74.83. St. Jude Medical Inc. fell$. 38 or. 6 percent, to $64.45.

  • Early Glance: Pharmaceuticals companies Friday, 12 Sep 2014 | 11:13 AM ET

    Baxter International Inc. fell$. 26 or. 3 percent, to $74.83. Bristol-Myers Squibb Co. fell$. 12 or. 2 percent, to $50.56. Hospira fell$. 07 or. 1 percent, to $52.92.

  • *BAT unit working with Kind Consumer, Consort Medical. LONDON, Sept 12- A new nicotine inhaler to be sold by British American Tobacco has been licensed in the UK as a medicinal product, marking the arrival of a novel alternative to the fast-growing market for electronic cigarettes.